Integrating
ratiometric photoelectrochemical (PEC) techniques with
paper microfluidics to construct a ratiometric PEC paper analytical
device for practical application is often restricted by the grave
dependence of ratiometric assay on photoactive materials and low mass-transfer
rates of the paper channel. Herein, a universal donor/acceptor-induced
ratiometric PEC paper analytical device with a hollow double-hydrophilic-walls
channel (HDHC) was fabricated for high-performance microRNA-141 (miRNA-141)
quantification. Concretely, a photoanode and photocathode were integrated
on the paper-based sensing platform in which the photocathode served
as a biosensing site for the pursuit of higher selectivity. For formulation
of a cascading signal amplification strategy, a unique duplex-specific
nuclease-induced target recycling reaction was engineered for the
output of a double amount of all useful DNA linkers instead of conventional
output of only one available DNA product, which could guarantee the
output of abundant DNA linkers with the initiation of a cascade of
hybridization chain reaction on both the trunk and branch in the presence
of miRNA-141. Then the formed dendriform polymeric DNA duplex structures
were further decorated with glucose oxidase (GOx)-mimicking gold nanoparticles
by the electrostatic interaction to form a branchy gold tree (BGT).
Profiting from the perfect GOx-mimicking activity of BGT and high
mass-transfer rates of HDHC, the cathodic photocurrent from Ag2S/Cu2O hybrid structure was in a “signal
off” state while the anodic photocurrent from graphene quantum
dots (GQDs) and Ag2Se QDs cosensitized ZnO nanosheets was
in a “signal on” state because BGT-catalyzed glucose
oxidation reaction evoked the consumption of dissolved O2 as an electron acceptor and the generation of H2O2 as an electron donor. With calculation of the ratio of two
photocurrent intensities, the quantitative detection of miRNA-141
was achieved with high sensitivity, accuracy, and reliability.
In
this work, a lab-on-paper cathode photoelectrochemical (PEC)
sensing platform was constructed for ultrasensitive microRNA-141 (miRNA-141)
assay using cascaded multiple photo-active structures as signal generators
and hemin/Pt nanoparticle (Pt NP) trunk-branching-decorated DNA dendrimers
as signal reinforcers. Specifically, pyramid-like Cu2O
was first in situ grown on the Au nanoparticle-functionalized tangled
cellulose fibers network, followed by the sensitization of trepang-like
BiVO4–Bi2S3 heterostructures,
forming the cascaded sensitization structures. Then, the DNA dendrimer
was introduced into the photocathode sensing interface by coupling
the duplex-specific-nuclease (DSN)-induced target recycling reaction
with multiple-branched hybridization chain reaction (MHCR). The programmed
target recycling procedures propelled using DSN guaranteed the highly
amplified transduction of miRNA-141 to the exposed initiator strand,
which triggered the cascaded MHCR accompanied by the formation of
the DNA dendrimer with unique trunk-branching structures. Finally,
the hemin/Pt NP trunk-branching-decorated DNA dendrimer (HPTD) was
acquired by the assembly of Pt NPs and hemin on the trunk and branch,
respectively. The resulting HPTD with the synergy catalysis of Pt
NPs and hemin could efficiently catalyze the decomposition of H2O2 for in situ generation of O2 as the
electron acceptor, leading to an enhanced photocurrent response. Based
on the target-dependent photocurrent enhancement, ultrasensitive determination
of miRNA-141 was realized with persuasive selectivity, high stability,
and excellent reproducibility. Thus, the proposed paper-based cathode
PEC sensing platform possessed promising application prospect in clinical
miRNA diagnosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.